提供学术论文选刊润色服务

医学

返回期刊列表

Review Cycle Records

Expert Opinion on Drug Discovery

Taylor & Francis SCIE 非OA

2026新锐 2区2025中科院 2区2025 JCR Q1

查看审稿周期计算与数据来源报告数据问题

64.5平均天数

62中位天数

18最短天数

110最长天数

1102025发文量

Paper Review Records

全部论文审稿周期

13 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接

41 天

Fatty acid amide hydrolase (FAAH) inhibitor design and preclinical studies: lessons learned from BIA 10–2474 and the challenges ahead

收稿 2026-06-25 录用 2026-08-05 发表 2026-08-19

作者Alessia Catalano; Filomena Fezza; Andrea Duranti; Maria Maddalena Cavalluzzi; Giovanni Lentini; Giuseppe Felice Mangiatordi; Marco Bruno Luigi Rocchi; Mauro Maccarrone

作者单位1. University of Bari Aldo Moro; 2. University of Rome “Tor Vergata”; 3. University of Urbino Carlo Bo; 4. National Research Council of Italy; 5. University of L’Aquila; 6. Santa Lucia IRCCS

PDF源文件 DOI 网页

91 天

A network-driven antiviral discovery pipeline for emerging RNA viruses: a critical perspective from the Red Mexicana de Desarrollo de Antivirales (RMDA)

收稿 2026-05-06 录用 2026-08-05 发表 2026-08-14

作者Luis Adrián De Jesús-González; Alan Orlando Santos-Mena; Carlos Noé Farfán-Morales; Moisés León-Juárez; José Manuel Reyes-Ruiz; Juan Fidel Osuna-Ramos; Carlos Daniel Cordero-Rivera; Selvin Noé Palacios-Rápalo; Flor Itzel Lira-Hernández; Rosa María Del Ángel

作者单位1. Instituto Mexicano del Seguro Social; 2. Center for Research and Advanced Studies (CIN VESTAV-IPN); 3. Unidad Cuajimalpa; 4. Instituto Nacional de Perinatología “Isidro Espinosa de los Reyes”; 5. Instituto Mexicano del Seguro Social (IMSS); 6. Universidad Veracruzana (UV); 7. Universidad Autónoma de Sinaloa (UAS); 8. Instituto Politécnico Nacional (IPN); 9. Institut Pasteur, Université Paris Cité

PDF源文件 DOI 网页

95 天

Foundation models for low-data drug discovery: mining heterogeneous public and proprietary data in neglected indications

收稿 2026-04-24 录用 2026-07-28 发表 2026-08-07

作者Michail Papadourakis; Evangelia Efraimia Amaxopoulou; Minos-Timotheos Matsoukas

作者单位1. Cloudpharm PC; 2. University of West Attica

PDF源文件 DOI 网页

42 天

Mössbauer spectroscopy in drug discovery: revealing Fe- and Fe-S cluster dependent targets

收稿 2026-06-16 录用 2026-07-28 发表 2026-08-05

作者Jiahua Chen; Trent Quist; Ronabelle Fang; Henry Thanh Nguyen; Maria-Eirini Pandelia

作者单位1. Brandeis University

PDF源文件 DOI 网页

43 天

Should C. elegans play a larger role in drug discovery for neurodegenerative diseases?

收稿 2026-06-15 录用 2026-07-28 发表 2026-08-05

作者Andrea Hinas; Christian G. Riedel

作者单位1. Stockholm University; 2. Karolinska Institute

PDF源文件 DOI 网页

110 天

An overview of the current animal models of Marburg virus disease for countermeasure development

收稿 2026-04-08 录用 2026-07-27 发表 2026-08-03

作者Takeshi Saito; Junki Maruyama; Ayato Takada

作者单位1. The University of Texas Medical Branch; 2. Hokkaido University; 3. University of Zambia

PDF源文件 DOI 网页

61 天

Targeting ferroptosis in lung cancer: emerging strategies and drug discovery opportunities

收稿 2026-05-20 录用 2026-07-20 发表 2026-07-31

作者Qianyi Chen; Hao Liu; Cien Sun; Ziming Wang; William C. Cho; Jianfei Shen

作者单位1. Taizhou Hospital of Zhejiang Province Affiliated to Zhejiang University; 2. Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University; 3. Queen Elizabeth Hospital

PDF源文件 DOI 网页

62 天

Can Artificial intelligence meaningfully shorten drug discovery timelines? Current evidence, roadblocks and future directions

收稿 2026-05-26 录用 2026-07-27 发表 2026-07-30

作者Juan Luis Fernández-Martínez

作者单位1. University of Oviedo

PDF源文件 DOI 网页

18 天

Advancing polypharmacology-based drug discovery using deep generative models

收稿 2026-06-29 录用 2026-07-17 发表 2026-07-21

作者Jürgen Bajorath

作者单位1. Lamarr Institute for Machine Learning and Artificial Intelligence, Rheinische Friedrich-Wilhelms-Universität

PDF源文件 DOI 网页

62 天

Radiolysis in drug discovery: molecular modification, repurposing, and mechanistic insights

收稿 2026-04-28 录用 2026-06-29 发表 2026-07-08

作者Ha-Yeon Song

作者单位1. Korea Atomic Energy Research Institute (KAERI)

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求，转成可验证的期刊方案

说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。

客户询问

我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？

CrushSCI回复

可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议: 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
数据库初筛: Environmental Technology & Innovation

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Expert Opinion on Drug Discovery

全部论文审稿周期

Fatty acid amide hydrolase (FAAH) inhibitor design and preclinical studies: lessons learned from BIA 10–2474 and the challenges ahead

A network-driven antiviral discovery pipeline for emerging RNA viruses: a critical perspective from the Red Mexicana de Desarrollo de Antivirales (RMDA)

Foundation models for low-data drug discovery: mining heterogeneous public and proprietary data in neglected indications

Mössbauer spectroscopy in drug discovery: revealing Fe- and Fe-S cluster dependent targets

Should C. elegans play a larger role in drug discovery for neurodegenerative diseases?

An overview of the current animal models of Marburg virus disease for countermeasure development

Targeting ferroptosis in lung cancer: emerging strategies and drug discovery opportunities

Can Artificial intelligence meaningfully shorten drug discovery timelines? Current evidence, roadblocks and future directions

Advancing polypharmacology-based drug discovery using deep generative models

Radiolysis in drug discovery: molecular modification, repurposing, and mechanistic insights

把投稿要求，转成可验证的期刊方案

联系 CrushSCI

扫码添加微信好友

正在维护

Expert Opinion on Drug Discovery

全部论文审稿周期

Fatty acid amide hydrolase (FAAH) inhibitor design and preclinical studies: lessons learned from BIA 10–2474 and the challenges ahead

A network-driven antiviral discovery pipeline for emerging RNA viruses: a critical perspective from the Red Mexicana de Desarrollo de Antivirales (RMDA)

Foundation models for low-data drug discovery: mining heterogeneous public and proprietary data in neglected indications

Mössbauer spectroscopy in drug discovery: revealing Fe- and Fe-S cluster dependent targets

Should C. elegans play a larger role in drug discovery for neurodegenerative diseases?

An overview of the current animal models of Marburg virus disease for countermeasure development

Targeting ferroptosis in lung cancer: emerging strategies and drug discovery opportunities

Can Artificial intelligence meaningfully shorten drug discovery timelines? Current evidence, roadblocks and future directions

Advancing polypharmacology-based drug discovery using deep generative models

Radiolysis in drug discovery: molecular modification, repurposing, and mechanistic insights

相关榜单与期刊入口